6.
Hilber B, Scholze P, Dorostkar M, Sandtner W, Holy M, Boehm S
. Serotonin-transporter mediated efflux: a pharmacological analysis of amphetamines and non-amphetamines. Neuropharmacology. 2005; 49(6):811-9.
DOI: 10.1016/j.neuropharm.2005.08.008.
View
7.
Baumann M, Ayestas Jr M, Partilla J, Sink J, Shulgin A, Daley P
. The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology. 2011; 37(5):1192-203.
PMC: 3306880.
DOI: 10.1038/npp.2011.304.
View
8.
Cheng Y, Prusoff W
. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol. 1973; 22(23):3099-108.
DOI: 10.1016/0006-2952(73)90196-2.
View
9.
Kristensen A, Andersen J, Jorgensen T, Sorensen L, Eriksen J, Loland C
. SLC6 neurotransmitter transporters: structure, function, and regulation. Pharmacol Rev. 2011; 63(3):585-640.
DOI: 10.1124/pr.108.000869.
View
10.
Schneider C, Rasband W, Eliceiri K
. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012; 9(7):671-5.
PMC: 5554542.
DOI: 10.1038/nmeth.2089.
View
11.
Pereira D, Schmitz Y, Meszaros J, Merchant P, Hu G, Li S
. Fluorescent false neurotransmitter reveals functionally silent dopamine vesicle clusters in the striatum. Nat Neurosci. 2016; 19(4):578-86.
PMC: 4853199.
DOI: 10.1038/nn.4252.
View
12.
Wall S, Gu H, Rudnick G
. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux. Mol Pharmacol. 1995; 47(3):544-50.
View
13.
Rannversson H, Wilson P, Kristensen K, Sinning S, Kristensen A, Stromgaard K
. Importance of the Extracellular Loop 4 in the Human Serotonin Transporter for Inhibitor Binding and Substrate Translocation. J Biol Chem. 2015; 290(23):14582-94.
PMC: 4505525.
DOI: 10.1074/jbc.M114.629071.
View
14.
Mayer F, Luf A, Nagy C, Holy M, Schmid R, Freissmuth M
. Application of a Combined Approach to Identify New Psychoactive Street Drugs and Decipher Their Mechanisms at Monoamine Transporters. Curr Top Behav Neurosci. 2016; 32:333-350.
DOI: 10.1007/7854_2016_63.
View
15.
Marvin J, Borghuis B, Tian L, Cichon J, Harnett M, Akerboom J
. An optimized fluorescent probe for visualizing glutamate neurotransmission. Nat Methods. 2013; 10(2):162-70.
PMC: 4469972.
DOI: 10.1038/nmeth.2333.
View
16.
Koepsell H
. Organic Cation Transporters in Health and Disease. Pharmacol Rev. 2019; 72(1):253-319.
DOI: 10.1124/pr.118.015578.
View
17.
Davis B, Nagarajan A, Forrest L, Singh S
. Mechanism of Paroxetine (Paxil) Inhibition of the Serotonin Transporter. Sci Rep. 2016; 6:23789.
PMC: 4817154.
DOI: 10.1038/srep23789.
View
18.
Jaronczyk M, Walory J
. Novel Molecular Targets of Antidepressants. Molecules. 2022; 27(2).
PMC: 8778443.
DOI: 10.3390/molecules27020533.
View
19.
Sabatini B, Tian L
. Imaging Neurotransmitter and Neuromodulator Dynamics In Vivo with Genetically Encoded Indicators. Neuron. 2020; 108(1):17-32.
DOI: 10.1016/j.neuron.2020.09.036.
View
20.
Fowler A, Seifert N, Acker V, Woehrle T, Kilpert C, de Saizieu A
. A nonradioactive high-throughput/high-content assay for measurement of the human serotonin reuptake transporter function in vitro. J Biomol Screen. 2006; 11(8):1027-34.
DOI: 10.1177/1087057106294698.
View